Veeco Instruments Inc.

First Quarter 2025 Highlights:

Revenue of $167.3 million, compared with $174.5 million in the same period last year GAAP net income of $11.9 million, or $0.20 per diluted share, compared with $21.9 million, or $0.37 per diluted share in the same period last year Non-GAAP net income of $22.2 million, or $0.37 per diluted share, compared with $26.4 million, or $0.45 per diluted share in the same period last year

PLAINVIEW, N.Y., May 07, 2025 (GLOBE NEWSWIRE) -- Veeco Instruments Inc. (Nasdaq: VECO) today announced financial results for its first quarter ended March 31, 2025. Results are reported in accordance with U.S. generally accepted accounting principles (“GAAP”) and are also reported adjusting for certain items (“Non-GAAP”). A reconciliation between GAAP and Non-GAAP operating results is provided at the end of this press release.

U.S. Dollars in millions, except per share data  GAAP Results  Q1 '25  Q1 '24 Revenue  $ 167.3   $ 174.5  Net income  $ 11.9   $ 21.9  Diluted earnings per share  $ 0.20   $ 0.37

Non-GAAP Results  Q1 '25  Q1 '24 Operating income  $ 24.3   $ 29.4  Net income  $ 22.2   $ 26.4  Diluted earnings per share  $ 0.37   $ 0.45

“Veeco delivered solid results during the first quarter, including sequential and year-over-year growth in our Semiconductor business driven by growth in Advanced Packaging,” commented Bill Miller, Ph.D., Veeco’s Chief Executive Officer. “In addition, Veeco shared several exciting announcements, including receipt of Intel’s 2025 EPIC supplier award, new application wins in Laser Annealing, and new application wins in Wet Processing. Each reflect our continued execution and confidence our long-term strategy can generate value for shareholders in the coming years.”

Guidance and Outlook

The following guidance is provided for Veeco’s second quarter 2025:

Revenue is expected in the range of $135 million to $165 million GAAP diluted earnings (loss) per share are expected in the range of ($0.05) to $0.17 Non-GAAP diluted earnings per share are expected in the range of $0.12 to $0.32

Conference Call Information

A conference call reviewing these results has been scheduled for today, May 7, 2025 starting at 5:00pm ET. To join the call, dial 1-877-407-8029 (toll-free) or 1-201-689-8029. Participants may also access a live webcast of the call by visiting the investor relations section of Veeco's website at ir.veeco.com. A replay of the webcast will be made available on the Veeco website that evening. We will post an accompanying slide presentation to our website prior to the beginning of the call.

Story Continues

About Veeco

Veeco (NASDAQ: VECO) is an innovative manufacturer of semiconductor process equipment. Our laser annealing, ion beam, single wafer etch & clean, lithography, and metal organic chemical vapor deposition (MOCVD) technologies play an integral role in the fabrication and packaging of advanced semiconductor devices. With equipment designed to optimize performance, yield and cost of ownership, Veeco holds leading technology positions in the markets we serve. To learn more about Veeco’s systems and service offerings, visit www.veeco.com.

Forward-looking Statements

This press release contains “forward-looking statements”, within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, as amended, that are based on management’s expectations, estimates, projections and assumptions. Words such as “expects,” “anticipates,” “plans,” “believes,” “scheduled,” “estimates” and variations of these words and similar expressions are intended to identify forward-looking statements. Forward-looking statements include, but are not limited to, those regarding anticipated growth and trends in our businesses and markets, industry outlooks and demand drivers, our investment and growth strategies, our development of new products and technologies, our business outlook for current and future periods, our ongoing transformation initiative and the effects thereof on our operations and financial results; and other statements that are not historical facts. These statements and their underlying assumptions are subject to risks and uncertainties and are not guarantees of future performance. Factors that could cause actual results to differ materially from those expressed or implied by such statements include, without limitation: the level of demand for our products; global economic and industry conditions; global trade issues, including the ongoing trade disputes between the U.S. and China, and changes in trade and export license policies; our dependency on third-party suppliers and outsourcing partners; the timing of customer orders; our ability to develop, deliver and support new products and technologies; our ability to expand our current markets, increase market share and develop new markets; the concentrated nature of our customer base; our ability to obtain and protect intellectual property rights in key technologies; the effects of regional or global health epidemics; our ability to achieve the objectives of operational and strategic initiatives and attract, motivate and retain key employees; the variability of results among products and end-markets, and our ability to accurately forecast future results, market conditions, and customer requirements; the impact of our indebtedness, including our convertible senior notes and our capped call transactions; and other risks and uncertainties described in our SEC filings on Forms 10-K, 10-Q and 8-K, and from time-to-time in our other SEC reports. All forward-looking statements speak only to management’s expectations, estimates, projections and assumptions as of the date of this press release or, in the case of any document referenced herein or incorporated by reference, the date of that document. The Company does not undertake any obligation to update or publicly revise any forward-looking statements to reflect events, circumstances or changes in expectations after the date of this press release.

-financial tables attached-

Veeco Contacts:

Investors:  Anthony Pappone  (516) 500-8798  [email protected] Media:  Javier Banos  (516) 673-7328  [email protected]

Veeco Instruments Inc. and Subsidiaries
Condensed Consolidated Statements of Operations
(in thousands, except per share amounts)
(unaudited)  Three months ended March 31,  2025  2024 Net sales $ 167,292   $ 174,484  Cost of sales  98,825    99,065  Gross profit  68,467    75,419  Operating expenses, net:  Research and development  28,514    29,642  Selling, general, and administrative  25,028    24,700  Amortization of intangible assets  821    1,891  Other operating expense (income), net  (44 )   (2,859 ) Total operating expenses, net  54,319    53,374  Operating income  14,148    22,045  Interest income (expense), net  836    705  Income (loss) before income taxes  14,984    22,750  Income tax expense (benefit)  3,037    896  Net income $ 11,947   $ 21,854   Income per common share:  Basic $ 0.21   $ 0.39  Diluted $ 0.20   $ 0.37   Weighted average number of shares:  Basic  57,753    55,968  Diluted  60,234    60,764

Veeco Instruments Inc. and Subsidiaries
Condensed Consolidated Balance Sheets
(in thousands)  March 31,   December 31,  2025  2024 (unaudited)  Assets  Current assets:  Cash and cash equivalents $ 174,898   $ 145,595  Restricted cash  169    224  Short-term investments  178,395    198,719  Accounts receivable, net  114,368    96,834  Contract assets  33,586    37,109  Inventories  254,051    246,735  Prepaid expenses and other current assets  39,338    39,316  Total current assets  794,805    764,532  Property, plant and equipment, net  113,787    113,789  Operating lease right-of-use assets  25,991    26,503  Intangible assets, net  8,010    8,832  Goodwill  214,964    214,964  Deferred income taxes  118,567    120,191  Other assets  2,700    2,766  Total assets $ 1,278,824   $ 1,251,577   Liabilities and stockholders’ equity  Current liabilities:  Accounts payable $ 57,845   $ 43,519  Accrued expenses and other current liabilities  62,257    55,195  Contract liabilities  57,211    64,986  Income taxes payable  1,546    2,086  Current portion of long-term debt  —    26,496  Total current liabilities  178,859    192,282  Deferred income taxes  663    689  Long-term debt  249,955    249,702  Long-term operating lease liabilities  33,694    34,318  Other liabilities  3,795    3,816  Total liabilities  466,966    480,807   Total stockholders’ equity  811,858    770,770  Total liabilities and stockholders’ equity $ 1,278,824   $ 1,251,577

Note on Reconciliation Tables

The below tables include financial measures adjusted for the impact of certain items; these financial measures are therefore not calculated in accordance with U.S. generally accepted accounting principles (“GAAP”). These Non-GAAP financial measures exclude items such as: share-based compensation expense; charges relating to restructuring initiatives; non-cash asset impairments; certain other non-operating gains and losses; and acquisition-related items such as transaction costs, non-cash amortization of acquired intangible assets, and certain integration costs.

These Non-GAAP financial measures may be different from Non-GAAP financial measures used by other companies. Non-GAAP financial measures should not be considered a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP. By excluding these items, Non-GAAP financial measures are intended to facilitate meaningful comparisons to historical operating results, competitors’ operating results, and estimates made by securities analysts. Management is evaluated on key performance metrics including Non-GAAP Operating income (loss), which is used to determine management incentive compensation as well as to forecast future periods. These Non-GAAP financial measures may be useful to investors in allowing for greater transparency of supplemental information used by management in its financial and operational decision-making. In addition, similar Non-GAAP financial measures have historically been reported to investors; the inclusion of comparable numbers provides consistency in financial reporting. Investors are encouraged to review the reconciliation of the Non-GAAP financial measures used in this news release to their most directly comparable GAAP financial measures.

Reconciliation of GAAP to Non-GAAP Financial Data (Q1 2025)
(in thousands)
(unaudited)  Non-GAAP Adjustments  Three months ended March 31, 2025  GAAP   Share-Based
Compensation  Amortization  Other  Non-GAAP  Net sales  $ 167,292         $ 167,292  Gross profit   68,467   1,343        69,810  Gross margin   40.9 %         41.7 % Operating expenses   54,319   (7,865 )  (821 )  (99 )   45,534  Operating income   14,148   9,208   821   99 ^   24,276  Net income   11,947   9,208   821   231 ^   22,207

_______________
^   - See table below for additional details.

Other Non-GAAP Adjustments (Q1 2025)
(in thousands)
(unaudited)  Three months ended March 31, 2025  Other $ 99  Subtotal  99  Non-cash interest expense  257  Non-GAAP tax adjustment *  (125 ) Total Other $ 231

_______________
*   - The ‘with or without’ method is utilized to determine the income tax effect of all Non-GAAP adjustments.

Net Income per Common Share (Q1 2025)
(in thousands, except per share amounts)
(unaudited)  Three months ended March 31, 2025 GAAP  Non-GAAP Numerator:  Net income $ 11,947   $ 22,207  Interest expense associated with 2025 and 2027 Convertible Senior Notes  253    273  Net income available to common shareholders $ 12,200   $ 22,480   Denominator:  Basic weighted average shares outstanding  57,753    57,753  Effect of potentially dilutive share-based awards  693    693  Dilutive effect of 2025 Convertible Senior Notes  —    174  Dilutive effect of 2027 Convertible Senior Notes (1)  1,788    1,354  Diluted weighted average shares outstanding  60,234    59,974   Net income per common share:  Basic $ 0.21   $ 0.38  Diluted $ 0.20   $ 0.37

_______________
(1) - The non-GAAP incremental dilutive shares includes the impact of the Company’s capped call transaction issued concurrently with our 2027 Notes, and as such, an effective conversion price of $18.46 is used when determining incremental shares to add to the dilutive share count. The GAAP incremental dilutive shares does not include the impact of the Company’s capped call transaction, and as such, an effective conversion price of $13.98 is used when determining incremental shares to add to the dilutive share count.

Reconciliation of GAAP to Non-GAAP Financial Data (Q1 2024)
(in thousands)
(unaudited)  Non-GAAP Adjustments  Three months ended March 31, 2024   GAAP  Share-based
Compensation  Amortization  Other  Non-GAAP  Net sales  $ 174,484         $ 174,484  Gross profit   75,419   1,730        77,149  Gross margin   43.2 %         44.2 % Operating expenses   53,374   (6,352 )  (1,891 )  2,658    47,789  Operating income   22,045   8,082   1,891   (2,658 ) ^  29,360  Net income   21,854   8,082   1,891   (5,384 ) ^  26,443

_______________
^   - See table below for additional details.

Other Non-GAAP Adjustments (Q1 2024)
(in thousands)
(unaudited)  Three months ended March 31, 2024  Changes in contingent consideration $ (625 ) Sale of productive assets  (2,033 ) Subtotal  (2,658 ) Non-cash interest expense  296  Non-GAAP tax adjustment *  (3,022 ) Total Other $ (5,384 )

_______________
*   - The ‘with or without’ method is utilized to determine the income tax effect of all Non-GAAP adjustments.

Net Income per Common Share (Q1 2024)
(in thousands, except per share amounts)
(unaudited)  Three months ended March 31, 2024 GAAP  Non-GAAP Numerator:  Net income $ 21,854   $ 26,443  Interest expense associated with 2025 and 2027 Convertible Senior Notes  514    466  Net income available to common shareholders $ 22,368   $ 26,909   Denominator:  Basic weighted average shares outstanding  55,968    55,968  Effect of potentially dilutive share-based awards  939    939  Dilutive effect of 2025 Convertible Senior Notes  1,104    1,104  Dilutive effect of 2027 Convertible Senior Notes (1)  1,788    1,354  Dilutive effect of 2029 Convertible Senior Notes  965    965  Diluted weighted average shares outstanding  60,764    60,330   Net income per common share:  Basic $ 0.39   $ 0.47  Diluted $ 0.37   $ 0.45

_______________
(1) - The non-GAAP incremental dilutive shares includes the impact of the Company’s capped call transaction issued concurrently with our 2027 Notes, and as such, an effective conversion price of $18.46 is used when determining incremental shares to add to the dilutive share count. The GAAP incremental dilutive shares does not include the impact of the Company’s capped call transaction, and as such, an effective conversion price of $13.98 is used when determining incremental shares to add to the dilutive share count.

Reconciliation of GAAP Net Income to Non-GAAP Operating Income (Q1 2025 and 2024)
(in thousands)
(unaudited)  Three months ended   Three months ended  March 31, 2025  March 31, 2024 GAAP Net income $ 11,947   $ 21,854  Share-based compensation  9,208    8,082  Amortization  821    1,891  Sale of productive assets  —    (2,033 ) Changes in contingent consideration  —    (625 ) Interest (income) expense, net  (836 )   (705 ) Other  99    —  Income tax expense (benefit)  3,037    896  Non-GAAP Operating income $ 24,276   $ 29,360

Reconciliation of GAAP to Non-GAAP Financial Data (Q2 2025)
(in millions, except per share amounts)
(unaudited)  Non-GAAP Adjustments  Guidance for the three months ending          Share-based  June 30, 2025  GAAP  Compensation  Amortization  Other  Non-GAAP Net sales  $ 135   -  $ 165         $ 135   -  $ 165  Gross profit   54   -   69   1   —   —    55   -   70  Gross margin   39 %  -   41 %         40 %  -   42 % Operating expenses   57   -   58   (9 )  (1 )  —    47   -   48  Operating income (loss)   (3 )  -   11   10   1   —    8   -   22  Net income (loss)  $ (3 )  -  $ 10   10   1   (1 )  $ 7   -  $ 20   Income (loss) per diluted common share  $ (0.05 )  -  $ 0.17         $ 0.12   -  $ 0.32

Income per Diluted Common Share (Q2 2025) 
(in millions, except per share amounts)
(unaudited)  Guidance for the three months ending June 30, 2025  GAAP  Non-GAAP Numerator:  Net income (loss) available to common shareholders  $ (3 )  -  $ 10   $ 7   -  $ 20   Denominator:  Basic weighted average shares outstanding   58      58    58      58  Effect of potentially dilutive share-based awards   —      1    1      1  Dilutive effect of 2027 Convertible Senior Notes (1)   —      2    —      1  Diluted weighted average shares outstanding   58      61    59      61   Net income per common share:  Income (loss) per diluted common share  $ (0.05 )  -  $ 0.17   $ 0.12   -  $ 0.32

_______________
(1) - The non-GAAP incremental dilutive shares includes the impact of the Company’s capped call transaction issued concurrently with our 2027 Notes, and as such, an effective conversion price of $18.46 is used when determining incremental shares to add to the dilutive share count. The GAAP incremental dilutive shares does not include the impact of the Company’s capped call transaction, and as such, an effective conversion price of $13.98 is used when determining incremental shares to add to the dilutive share count.

Reconciliation of GAAP Net Income to Non-GAAP Operating Income (Q2 2025)
(in millions)
(unaudited)  Guidance for the three months ending June 30, 2025  GAAP Net income (loss)  $ (3 )  -  $ 10  Share-based compensation   10   -   10  Amortization   1   -   1  Interest income, net   (1 )  -   (1 ) Income tax expense (benefit)   —   -   1  Non-GAAP Operating income  $ 8   -  $ 22

Note: Amounts may not calculate precisely due to rounding.

View Comments